Strs Ohio Alnylam Pharmaceuticals, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Strs Ohio holds 29,468 shares of ALNY stock, worth $7.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

29,468

Previous 25,000 17.87%

Holding current value

$7.6 Million

Previous $6.08 Million 33.43%

% of portfolio

0.03%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$233.81 - $287.01 $1.04 Million - $1.28 Million	4,468 Added 17.87%	29,468 $8.11 Million
Q3 2023 Oct 26, 2023	SELL	$170.77 - $211.65 $853,850 - $1.06 Million	-5,000 Reduced 16.67%	25,000 $4.43 Million
Q2 2023 Jul 31, 2023	BUY	$185.01 - $212.05 $4.71 Million - $5.4 Million	25,472 Added 562.54%	30,000 $5.7 Million
Q1 2023 Aug 02, 2023	SELL	$182.66 - $235.53 $4.65 Million - $6 Million	-25,472 Reduced 84.91%	4,528 $907,000
Q1 2023 Apr 27, 2023	BUY	$182.66 - $235.53 $165,307 - $213,154	905 Added 24.98%	4,528 $907,000
Q4 2022 Jan 26, 2023	BUY	$185.53 - $241.31 $57,885 - $75,288	312 Added 9.42%	3,623 $861,000
Q3 2022 Oct 27, 2022	BUY	$138.54 - $232.0 $458,705 - $768,152	3,311 New	3,311 $662,000
Q2 2022 Jul 25, 2022	SELL	$120.42 - $169.29 $637,142 - $895,713	-5,291 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$127.18 - $173.91 $508,720 - $695,640	4,000 Added 309.84%	5,291 $863,000
Q2 2021 Jul 26, 2021	SELL	$128.63 - $176.89 $389,620 - $535,799	-3,029 Reduced 70.12%	1,291 $218,000
Q1 2021 Apr 23, 2021	SELL	$126.83 - $175.69 $19,024 - $26,353	-150 Reduced 3.36%	4,320 $609,000
Q4 2020 Jan 25, 2021	SELL	$122.97 - $147.0 $869,274 - $1.04 Million	-7,069 Reduced 61.26%	4,470 $580,000
Q3 2020 Dec 14, 2020	SELL	$121.19 - $165.49 $49,566 - $67,685	-409 Reduced 3.42%	11,539 $1.68 Million
Q2 2020 Jul 23, 2020	BUY	$104.21 - $156.44 $838,473 - $1.26 Million	8,046 Added 206.2%	11,948 $1.77 Million
Q1 2020 Apr 23, 2020	BUY	$93.12 - $133.99 $263,995 - $379,861	2,835 Added 265.7%	3,902 $424,000
Q1 2019 Apr 19, 2019	SELL	$72.76 - $93.45 $226,647 - $291,096	-3,115 Reduced 74.49%	1,067 $99,000
Q2 2018 Aug 06, 2018	BUY	$88.31 - $107.8 $273,761 - $334,180	3,100 Added 286.51%	4,182 $411,000
Q1 2018 Apr 20, 2018	SELL	$115.92 - $148.54 $4,057 - $5,198	-35 Reduced 3.13%	1,082 $128,000
Q4 2017 Jan 23, 2018	BUY	$114.49 - $139.98 $127,885 - $156,357	1,117	1,117 $141,000

Others Institutions Holding ALNY

# of Institutions

639

Shares Held

108M

Call Options Held

1.15M

Put Options Held

1.07M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.7B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account